<DOC>
	<DOCNO>NCT01173822</DOCNO>
	<brief_summary>The study randomize control trial ( RCT ) 198 coronary artery bypass graft ( CABG ) patient , explore whether ultrafiltration residual blood cardiopulmonary bypass circuit reduce transfusion bleeding .</brief_summary>
	<brief_title>Processed Residual Pump Blood Cardiac Surgery : The PRBC Trial</brief_title>
	<detailed_description>Blood product limit resource cardiac surgery high consumer . Processing residual cardiopulmonary bypass ( CPB ) volume via ultrafiltration may improve hemostasis reduce transfusion clearing activate complement , activate coagulation component , proinflammatory cytokine . Unlike cell saver technology , ultrafiltration advantage maintain plasma protein , platelet , coagulation factor . We seek establish processing residual CPB volume ultrafiltration reduce homologous blood transfusion bleeding .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<criteria>least 18 year age undergo isolated onpump CABG able give inform consent perform autologous blood donation underwent offpump CABG emergency procedure resternotomy know bleed disorder drug relate history heparininduced thrombocytopenia Jehovah 's Witness intraoperative catastrophe prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>cardiopulmonary bypass</keyword>
	<keyword>hemorrhage</keyword>
	<keyword>trial</keyword>
	<keyword>surgery</keyword>
</DOC>